Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Erectile Dysfunction Management in Young Males

Initial Evaluation and Assessment

  • The American Urological Association recommends a comprehensive evaluation focusing on psychosocial factors, cardiovascular risk markers, and hormonal status for men under 30 presenting with erectile dysfunction, followed by first-line treatment with PDE5 inhibitors while addressing underlying psychological and lifestyle factors 1, 2
  • The physician must initiate the sexual health inquiry, as young men are often uncomfortable broaching this topic 1
  • Assessing sexual history, including libido, ejaculatory function, orgasmic capacity, morning erections, and ability to achieve erections with masturbation, is crucial 1, 2
  • Screening for psychosocial factors such as depression, anxiety, performance anxiety, relationship quality, stress, and partner sexual function is essential 1, 2

Investigations and Testing

  • Morning serum total testosterone measurement is mandatory for all men with ED, as it helps identify hypogonadism 1, 3, 5
  • Fasting glucose or HbA1c screening is necessary to identify diabetes, which may be the first presenting symptom of ED 3, 5
  • Fasting lipid profile assessment is crucial to evaluate cardiovascular risk 3, 5

Treatment Approach

  • The American Urological Association recommends phosphodiesterase-5 inhibitors (PDE5i) as the most effective first-line treatment for ED, with 60-65% success rates even in men with comorbidities 3
  • Mental health referral should be strongly considered in men under 30, as psychogenic factors are predominant in this age group 1, 2, 3
  • Cognitive behavioral therapy and couples counseling are effective psychological interventions for ED 1

Follow-Up and Monitoring

  • Reassessing patients at 4-6 weeks after initiating PDE5i therapy using validated questionnaires is recommended 1, 2
  • Monitoring cardiovascular risk factors periodically is crucial, as ED and cardiovascular disease share pathophysiologic pathways 3

REFERENCES

1

erectile dysfunction: aua guideline. [LINK]

The Journal of urology, 2018

2

erectile dysfunction: aua guideline. [LINK]

The Journal of urology, 2018

3

Erectile Dysfunction Evaluation and Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Laboratory Testing for Erectile Dysfunction [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025